Dr. Jacob Glickman is a Medical Director at Regeneron. As a board-certified dermatologist and physician-scientist with an MD and a PhD in immunology from the Icahn School of Medicine at Mount Sinai, he is focused on leveraging technology to improve patient outcomes.
Beyond his clinical and corporate roles, his experience in venture capital and consulting points to a broader interest in the business and innovation side of life sciences. He has actively explored how new technologies and companies can shape the future of medicine.
He uniquely combines clinical dermatology, deep immunology research, a background in bioinformatics, and experience in the venture capital space.